Direct-acting Antivirals Inducing HCV-RNA Sustained Suppression Improve Xerophthalmia in HCV-infected Patients.
Caroleo B, Colangelo L, Donato M, Balestrieri M, Soda M, Palleria C, Sambataro G, Cosentino S, Muraca L, Alcaro T, Scorcia V, De Sarro G, Gallelli L.
Caroleo B, et al. Among authors: de sarro g.
Curr Rev Clin Exp Pharmacol. 2022;17(2):156-160. doi: 10.2174/2772432816666210903150454.
Curr Rev Clin Exp Pharmacol. 2022.
PMID: 34477542